Nigeria vs Syrian Arab Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Nigeria
2.7%
in 2024
Syrian Arab Republic
2.9%
in 2024
Nigeria rank
9th
Syrian Arab Republic rank
6th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Nigeria
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 2.9% against 2.7% in Nigeria, a difference of 0.2%.
That makes Syrian Arab Republic's figure about 1.1 times Nigeria's.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Nigeria ahead.
Nigeria ranks 9th and Syrian Arab Republic ranks 6th of 247 countries.
Across the 2 decades both report, Nigeria averaged higher in 1 and Syrian Arab Republic in 1.
Head to head by decade
| Decade | Nigeria | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.7% | 3.5% | 0.3% | Nigeria |
| 2020s | 3.1% | 3.4% | 0.3% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Nigeria or Syrian Arab Republic?
- Syrian Arab Republic, at 2.9% against 2.7% in Nigeria as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Nigeria and Syrian Arab Republic?
- 0.2%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Nigeria and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do Nigeria and Syrian Arab Republic rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Nigeria ranks 9th and Syrian Arab Republic ranks 6th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.